When it comes to investing in general, investors should not lock themselves into any single way of looking at stocks. Cheap stocks don’t always do the best. More...READ MORE
The Fund invests in individual stocks that have exposure to multiple market anomalies, while using a tactical model to dynamically adjust portfolio risk.
The Fund uses price-driven trend-following models to tactically allocate the portfolio in order to manage risk.
Counterpoint’s empirical research of market history has shown price levels can be an effective predictor of future volatility, and can be utilized to seek an improvement to risk-adjusted returns relative to passive benchmarks.
The Fund selects the particular stocks on which to go long and short based on quantitative models. The models are based on proprietary research related to economic indicators found in peer-reviewed academic journals. The target portfolio typically holds:
• More than 600 individual securities
• Invests in both US and International developed-market stocks
• Targets sector and currency neutrality.
The Fund’s ranking model is based on research of investment anomalies found in peer-reviewed academic journals, and uses machine-learning techniques to most optimally score the universe of input stocks. The Fund seeks to target the best performing, recent, and persistent anomalies. The Fund’s strategy is multi-factor, and seeks to capitalize on many market anomalies at any one time.
Using a disciplined tactical market model based on trend-following methodologies, the Fund seeks to avoid downside risk by alternating between “Risk On” (0.80 to 0.85 beta to S&P 500) and “Risk Off” (zero beta to S&P 500) target asset allocations.
Historical analysis suggests that when the model signaled to reduce equity risk, the following month’s realized market volatility in avoided equities was on average 96% higher versus when the model signaled to hold equities.
There is no guarantee that any investment strategy will achieve its objectives, generate profits or avoid losses.
Watch Chief Research Officer, Joseph Engelberg and Daniel Krause, Head of Sales & Partner at Counterpoint Mutual Funds, provide an update on Counterpoint’s Equity strategy and some significant...READ MORE
Watch Chief Research Officer, Joseph Engelberg and Daniel Krause, Partner at Counterpoint Mutual Funds, provide an update on Counterpoint’s Tactical Equity Fund, as well as share our findings...READ MORE
|As of December 06, 2023||As of September 30, 2023|
|Return Since Fund Inception (Annualized)||Year to Date||1 Year Return||Standard Deviation (Annualized)||Return Since Fund Inception (Annualized)||Year To Date||1 Year Return||3 Year Return (Annualized)||5 Year Return (Annualized)|
Without Sales Load
With Sales Load (5.75%)
The performance data displayed here represents past performance, which is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. The investment return and principal value of an investment will fluctuate so that investor’s shares, when redeemed, may be worth more or less than their original cost. A shares (CPAEX) have a Front-End Sales Charge (commission or “load”) of 5.75%, with lower rates for accounts over $25,000, and 12b-1 distribution fee of 0.25% per year. For performance information current to the most recent month-end, please call toll-free 844-273-8637.
The Counterpoint Tactical Equity Fund seeks to provide capital appreciation while managing downside risk. The Fund invests in individual stocks that have exposure to multiple market anomalies, while using a tactical model to dynamically adjust portfolio risk.
The Counterpoint Tactical Equity Fund Blended Index is a composite of 50% of the S&P 500 Total Return Index and 50% of the Bloomberg 1-3 Month U.S. Treasury Bill Index. Index returns assume reinvestment of dividends. Investors may not invest in the Index directly. Unlike the Fund’s returns, the Index does not reflect any fees or expenses.
|Share Class||Class A||Class C||Institutional|
|Minimum IRA Investment||$1,000||$1,000||$100,000|
|Other Fund Expenses (Maximum Net of Waiver)||0.79% (0.50%)||0.79% (0.50%)||0.79% (0.50%)|
|Interest/Dividend Expense on Securities Sold Short and Acquired Fund Fees and Expenses||0.08%||0.08%||0.08%|
|12b-1 Distribution & Marketing||0.25%||1.00%||None|
|Total Annual Operating Fees||2.40%||3.15%||2.15%|
|Total Annual Fund Operating Expenses After Fee Waiver||2.11%||2.86%||1.86%|
|Fund Inception Date||November 30, 2015|
The Fund’s investment adviser has contractually agreed to reduce its fees and/or absorb expenses of the Fund, at least until January 31, 2022 to ensure that the net annual fund operating expenses exclusive of Acquired Fund Expenses will not exceed 2.00%, 2.75%, and 1.75% attributable to Class A, Class C, and Class I shares, subject to possible recoupment from the Fund in future years.
|Top Ten Holdings – as of November 30, 2023|
|Fidelity Treasury Portfolio||23.77%|
|United States Treasury Bill||15.18%|
|United States Treasury Bill||3.64%|
|COUNTERPOINT QUANTITATIVE EQUITY ETF||2.94%|
|JPM IND LONG 1||1.43%|
|S&P Emini 1st Wee Jan24C 1EF4C 4570 Index||0.48%|
|Oscar Health Inc.||0.47%|
|Triumph Group Inc.||0.44%|
|Proto Labs Inc.||0.43%|
Portfolio holdings are subject to change, vary over time and should not be considered a recommendation to buy any individual security.
Mutual Funds involve risk including the possible loss of principal. The use of leverage by the Fund or an Underlying Fund, such as borrowing money to purchase securities or the use of derivatives, will indirectly cause the Fund to incur additional expenses and magnify the Fund’s gains or losses. Derivative instruments involve risks different from, or possibly greater than, the risks associated with investing directly in securities and other traditional investments. There is a risk that issuers and counterparties will not make payments on securities and other investments held by the Fund, resulting in losses to the Fund. Past performance is no guarantee of future results. There is no assurance the Funds will meet their stated objectives.
Standard deviation is a measure of dispersion of returns from its mean return. Higher deviation represents higher volatility. Beta is a measure of the fund’s sensitivity to market movements. Beta greater than 1 is more volatile than the market; beta lower than 1 is less volatile than the market. Alpha refers to excess returns earned on an investment above the benchmark return not explained by known risk factors
We’ve received your request for the featured event collateral. A Counterpoint Funds team member will be in touch shortly.
Subscribe to stay up to date on and receive our monthly perspective.
We’ve received your meeting request and a Counterpoint Funds team member will be in touch shortly.
Subscribe to stay up to date on and receive our monthly perspective.
We’ve received your event registration request and will be in touch shortly.
Subscribe to stay up to date on Counterpoint Funds and receive our monthly perspective.
We have received your application and look forward to reviewing your qualifications for the role. If your application seems like a good fit, we will contact you to discuss next steps.
Thank you again for your application and interest in joining the Counterpoint team!
We’ve received your message. A Counterpoint Funds team member will contact you soon.
Subscribe to stay up to date and receive our monthly perspective.